Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Neuroinfectious Diseases received 739 citations as per Google Scholar report
Emerging Medicines in Multiple Sclerosis
Multiple sclerosis (MS) is a progressive autoimmune neurological condition that mostly affects young adults and may be debilitating. Multiple sclerosis (MS) is currently treated with a number of disease-modifying medications (DMDs) (MS). There has been a surge in the discovery and advancement of possible novel drugs for MS, including oral therapies... Read More»
: J Neuroinfect Dis
10.4172/2314-7326.1000320Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals